ChromaDex Corporation
(NASDAQ:CDXC)

ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplem...

Website: http://www.chromadex.com

Full Time Employees: 110

Sector: Healthcare

Industry: Biotechnology

Biotechnology

Share this website to your friends

• Market Cap:

• Exchange:

• Shs Outstanding:

• Employees:

• Beta:

• Return on Equity (ROE) ttm:

• Return on Assets (ROA) ttm:

• EPS ttm:

• Book value per Share:

• Cash per Share:

• Current ast per Share:

• P/E ttm:

• P/E forward:

• P/E ttm high:

• P/E ttm low:

• P/S ttm:

• P/B ttm:

• P/FCF ttm:

• PEG ratio:

• Cash Ratio ttm:

• Quick Ratio ttm:

• Current Ratio ttm:

• Gross Mgn ttm:

• EBITDA Mgn ttm:

• Operating Mgn ttm:

• Net Income Mgn ttm:

• Trailing Div yield:

• Forward Div yield:

• Payout Ratio ttm:

• Ex-Dividend date:

• Target Price High:

• Target Price Low:

• Target Price Mean:

• Number of Analysts:

• Debt Ratio ttm:

• Debt to Equity ttm:

• Total Net Debt:

At a glance:

Bull Thesis:

Bear Thesis:

Main Competitors:

Moat:

Income Statements:

Quarterly

Annual

Unit: USD	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-30	2017-09-30	2017-07-01	2017-04-01	2016-12-31	2016-10-01	2016-07-02	2016-04-02	2016-01-02	2015-10-03	2015-07-04	2015-04-04	2015-01-03	2014-09-27	2014-06-28	2014-03-29	2013-12-28	2013-09-28	2013-03-30	2012-12-29	2012-09-29	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-07-02	2011-04-02	2011-01-01	2010-10-02	2010-07-03	2010-04-03	2010-01-02	2009-10-03	2009-07-04	2009-04-04	2009-01-03	2008-09-27	2008-06-28

sales	33,839,000	33,986,000	31,117,000	30,481,000	29,125,000	25,580,000	22,739,000	22,153,000	21,196,000	19,495,000	20,323,000	22,556,000	20,996,000	17,063,000	16,732,000	17,259,000	17,759,000	17,308,000	17,699,000	14,683,000	15,445,000	14,180,000	15,287,000	14,345,000	13,089,000	12,053,000	11,101,000	10,048,000		8,120,000	7,803,000	6,567,000		6,084,690	5,306,855	4,449,122		5,007,450	8,829,579	7,331,945		6,287,309	6,101,380	5,260,971		4,139,710	3,856,154	3,074,138	7,442,757	2,718,207	2,334,566		8,087,860	2,670,611	1,785,006	1,807,821	1,827,568	1,937,976	2,539,245	2,032,565	1,562,352	2,033,861	1,937,592	1,554,936	1,433,086	1,342,716	1,447,127	1,178,696	1,069,003	1,198,885
cost of sales	12,135,000	12,058,000	10,891,000	11,150,000	10,928,000	9,340,000	9,046,000	8,697,000	8,259,000	7,526,000	7,967,000	9,038,000	8,980,000	6,856,000	6,690,000	6,727,000	6,891,000	6,730,000	6,889,000	5,449,000	6,024,000	5,726,000	6,199,000	6,034,000	5,624,000	5,304,000	4,847,000	4,747,000		3,759,000	3,957,000	3,430,000		3,169,321	3,044,086	2,696,469		2,964,980	4,702,132	3,880,526		3,805,679	3,630,688	3,333,347		2,616,764	2,457,388	2,089,130	5,059,808	1,968,020	1,661,726		6,673,127	1,905,916	2,389,220	1,403,783	1,361,101	1,357,058	1,518,850	1,184,108	1,059,626	1,258,172	1,119,619
gross profit	21,704,000	21,928,000	20,226,000	19,331,000	18,197,000	16,240,000	13,693,000	13,456,000	12,937,000	11,969,000	12,356,000	13,518,000	12,016,000	10,207,000	10,042,000	10,532,000	10,868,000	10,578,000	10,810,000	9,234,000	9,421,000	8,454,000	9,088,000	8,311,000	7,465,000	6,749,000	6,254,000	5,301,000		4,361,000	3,846,000	3,137,000		2,915,369	2,262,769	1,752,653		2,042,470	4,127,447	3,451,419		2,481,630	2,470,692	1,927,624		1,522,946	1,398,766	985,008	2,382,949	750,187	672,840		1,414,733	764,695	-604,214	404,038	466,467	580,918	1,020,395	848,457	502,726	775,689	817,973	615,669	480,043	477,645	468,073	278,913	187,164	365,980
yoy	19.27%	35.02%	47.71%	43.66%	40.66%	35.68%	10.82%	-0.46%	7.66%	17.26%	23.04%	28.35%	10.56%	-3.51%	-7.10%	14.06%	15.36%	25.12%	18.95%	11.11%	26.20%	25.26%	45.31%	56.78%		54.76%	62.61%	68.98%		49.59%	69.97%	78.99%		42.74%	-45.18%	-49.22%		-17.70%	67.06%	79.05%		62.95%	76.63%	95.70%		103.01%	107.89%		68.44%	-1.90%	-211.36%		203.29%	31.64%	-159.21%	-52.38%	-7.21%	-25.11%	24.75%	37.81%	4.73%	62.40%	74.75%	120.74%	156.48%	30.51%
qoq	-1.02%	8.41%	4.63%	6.23%	12.05%	18.60%	1.76%	4.01%	8.09%	-3.13%	-8.60%	12.50%	17.72%	1.64%	-4.65%	-3.09%	2.74%	-2.15%	17.07%	-1.98%	11.44%	-6.98%	9.35%	11.33%	10.61%	7.91%	17.98%			13.39%	22.60%			28.84%	29.11%			-50.51%	19.59%			0.44%	28.17%			8.88%	42.01%	-58.66%	217.65%	11.50%			85.01%	-226.56%	-249.54%	-13.38%	-19.70%	-43.07%	20.26%	68.77%	-35.19%	-5.17%	32.86%	28.25%	0.50%	2.04%	67.82%	49.02%	-48.86%
operating expenses:
sales and marketing	10,414,000	8,768,000	8,207,000	8,117,000	8,716,000	7,044,000	6,969,000	6,740,000	6,520,000	6,035,000	6,009,000	7,874,000	6,187,000	5,868,000	8,021,000	8,237,000	8,641,000	7,221,000	6,232,000	6,258,000	6,319,000	5,223,000	4,959,000	4,447,000	5,108,000	4,626,000	4,308,000	4,174,000		4,837,000	3,773,000	3,269,000		1,103,157	728,299	596,162		447,985	698,031	544,722		550,878	639,748	585,777		518,662	571,548	464,567	1,852,537	505,068	729,424		4,529,251	1,868,418	1,858,662	877,254	650,516	565,975	445,507	396,958	235,582	228,351	224,619
research and development	1,710,000	1,795,000	1,567,000	1,258,000	1,315,000	1,290,000	1,316,000	2,095,000	1,159,000	1,241,000	1,365,000	1,193,000	1,279,000	1,224,000	1,245,000	1,078,000	1,045,000	996,000	1,004,000	824,000	991,000	880,000	942,000	919,000	1,139,000	1,044,000	1,069,000	1,168,000		1,350,000	1,414,000	1,439,000		1,040,561	849,962	664,190		772,799	751,726	464,072
general and administrative	7,477,000	7,129,000	7,267,000	5,184,000	1,055,000	6,304,000	5,664,000	5,352,000	5,426,000	5,840,000	7,298,000	6,419,000	5,994,000	6,180,000	7,163,000	8,949,000	6,498,000	11,202,000	9,128,000	9,514,000	8,192,000	6,547,000	6,874,000	8,835,000	10,078,000	7,967,000	7,932,000	8,331,000		6,770,000	6,596,000	6,828,000		3,948,435	2,657,573	2,383,146		1,768,402	2,306,559	1,988,559		1,753,622	2,015,004	2,247,931		1,651,718	2,468,646	2,337,663	3,663,405	1,453,611	1,359,901		6,829,359	2,883,728	1,961,912	2,010,602	2,213,636	1,849,733	1,722,834	1,341,102	1,140,815	840,538	554,033	528,967	463,618	544,964	566,643	696,808	707,095	832,374
total operating expenses	17,618,000	17,692,000	17,041,000	14,559,000	11,086,000	14,638,000	13,949,000	14,187,000	13,105,000	13,116,000	14,672,000	15,486,000	13,460,000	13,272,000	16,429,000	18,264,000	16,184,000	19,419,000	16,364,000
operating income	4,086,000	4,236,000	3,185,000	4,772,000	7,111,000	1,602,000	-256,000	-731,000	-168,000	-1,147,000	-2,316,000	-1,968,000	-1,444,000	-3,065,000	-6,387,000	-7,732,000	-5,316,000	-8,841,000	-5,554,000	-7,362,000	-6,081,000	-4,196,000	-3,687,000	-5,890,000	-8,860,000	-6,888,000	-7,180,000	-8,372,000		-8,596,000	-7,937,000	-8,399,000		-3,176,784	-2,718,838	-1,890,845		-946,716	371,131	454,066		177,130	-184,060	-906,084		-647,434	-1,641,428	-1,838,765	-3,144,673	-1,241,773	1,475,432		-9,943,877	-3,987,451	-4,424,788	-2,483,818	-2,397,685	-1,834,790	-1,147,946	-889,603	-873,671	-293,200	39,321	-111,896	-173,728	-286,915	-320,192	-628,434	-698,370	-625,952
yoy	-42.54%	164.42%	-1344.14%	-752.80%	-4332.74%	-239.67%	-88.95%	-62.86%	-88.37%	-62.58%	-63.74%	-74.55%	-72.84%	-65.33%	15.00%	5.03%	-12.58%	110.70%	50.64%	24.99%	-31.37%	-39.08%	-48.65%	-29.65%		-19.87%	-9.54%	-0.32%		170.59%	191.93%	344.19%		235.56%	-832.58%	-516.43%		-634.48%	-301.64%	-150.11%		-127.36%	-88.79%	-50.72%		-47.86%	-211.25%		-68.38%	-68.86%	-133.34%		314.73%	117.32%	285.45%	179.21%	174.44%	525.78%	-3019.42%	695.03%	402.90%	2.19%	-112.28%	-82.19%	-75.12%	-54.16%
qoq	-3.54%	33.00%	-33.26%	-32.89%	343.88%	-725.78%	-64.98%	335.12%	-85.35%	-50.47%	17.68%	36.29%	-52.89%	-52.01%	-17.40%	45.45%	-39.87%	59.18%	-24.56%	21.07%	44.92%	13.81%	-37.40%	-33.52%	28.63%	-4.07%	-14.24%			8.30%	-5.50%			16.84%	43.79%			-355.09%	-18.26%			-196.23%	-79.69%			-60.56%	-10.73%	-41.53%	153.24%	-184.16%			149.38%	-9.88%	78.14%	3.59%	30.68%	59.83%	29.04%	1.82%	197.98%	-845.66%	-135.14%	-35.59%	-39.45%	-10.39%	-49.05%	-10.01%	11.57%
nonoperating income:																											-575,000	35,000
interest income	552,000	564,000	552,000	459,000	373,000	276,000	241,000	239,000	282,000	188,000	125,000	66,000												-12,000				35,000								2		565	638	794		976	645	718		230	305	640	1,072	179	884		2,725	1,056	1,199	238	295	430	-434	-450	-578	-397	-120	-120	-122	-417	-1,595	-6,027	-12,154	-11,550
income before provision for income taxes	4,424,000	4,800,000	3,737,000	5,231,000
provision for income taxes	292,000	222,000	128,000	168,000
net income	4,132,000	4,578,000	3,609,000	5,063,000	7,179,000	1,878,000	-15,000	-492,000	114,000	-959,000	-2,191,000	-1,902,000	-1,418,000	-985,000	-6,397,000	-7,740,000	-5,325,000	-8,856,000	-5,566,000	-7,381,000	-6,097,000	-4,215,000	-3,711,000	-5,902,000	-8,853,000	-7,202,000	-7,755,000	-8,337,000		-8,605,000	-8,050,000	-8,443,000		2,137,077	-2,764,124	-1,928,755		-954,390	-82,667	255,625		-3,716	-315,192	-1,025,515		-659,653	-1,653,142	-1,848,016	-3,169,262	-1,250,263	1,468,525		-9,963,844	-3,993,957	-4,431,853	-2,491,118	-2,404,912	-1,842,569	-1,156,385	-898,666	-883,223	-303,529	33,742	-115,081	-177,544	-291,100	-323,842	-649,547	-710,347	-621,676
yoy	-42.44%	143.77%	-24160.00%	-1129.07%	6197.37%	-295.83%	-99.32%	-74.13%	-108.04%	-2.64%	-65.75%	-75.43%	-73.37%	-88.88%	14.93%	4.86%	-12.66%	110.11%	49.99%	25.06%	-31.13%	-41.47%	-52.15%	-29.21%		-16.30%	-3.66%	-1.26%		-502.65%	191.23%	337.74%		-323.92%	3243.68%	-854.53%		25583.26%	-73.77%	-124.93%		-99.44%	-80.93%	-44.51%		-47.24%	-212.57%		-68.19%	-68.70%	-133.14%		314.31%	116.76%	283.25%	177.20%	172.29%	507.05%	-3527.14%	680.90%	397.47%	4.27%	-110.42%	-82.28%	-75.01%	-53.17%
qoq	-9.74%	26.85%	-28.72%	-29.47%	282.27%	-12620.00%	-96.95%	-531.58%	-111.89%	-56.23%	15.19%	34.13%	43.96%	-84.60%	-17.35%	45.35%	-39.87%	59.11%	-24.59%	21.06%	44.65%	13.58%	-37.12%	-33.33%	22.92%	-7.13%	-6.98%			6.89%	-4.65%			-177.31%	43.31%			1054.50%	-132.34%			-98.82%	-69.27%			-60.10%	-10.55%	-41.69%	153.49%	-185.14%			149.47%	-9.88%	77.91%	3.58%	30.52%	59.34%	28.68%	1.75%	190.98%	-999.56%	-129.32%	-35.18%	-39.01%	-10.11%	-50.14%	-8.56%	14.26%
net income per share
basic	0.05	0.06	0.05	0.07	0.09	0.02
diluted	0.05	0.05	0.04	0.06	0.09	0.02
weighted-average common shares outstanding:
basic	79,178	79,779	79,249	77,810	75,929	75,972
diluted	85,436	86,619	86,241	83,232	78,125	77,768
basic and diluted loss per common share attributable to chromadex corporation								-10		-10	-30	-30	-55	-10
basic and diluted weighted-average common shares outstanding							75,559,000	75,230,000	74,985,000	75,050,000	74,967,000	74,796,000	69,729,000	68,345,000	68,336,000	68,314,000	67,185,000	68,236,000	67,986,000	64,164,000	61,067,000			59,782,000	57,056,000		55,539,000	55,325,000	55,006,000		54,892,000	54,858,000	44,598,879		42,121,150			37,868,672	36,990,032			107,442,916	107,409,894	107,198,597	106,459,379	106,610,400	106,185,584	106,076,361	99,987,443	101,309,939		90,268,802	89,477,758	91,362,664	84,706,196	68,306,812	70,625,913
nonoperating income																								-12,000																									-2,122.5	-8,490
other income, net - employee retention tax credit														2,085,000
interest expense													-5,750	-5,000	-10,000	-8,000	-9,000	-15,000	-12,000	-19,000	-16,000	-19,000	-24,000		7,000	-314,000	-575,000			-9,000	-48,000	-44,000		-44,508	-45,286	-37,912		-11,392	-145,424	-188,495		-181,822	-131,777	-120,149		-12,449	-12,019	-9,891	-25,661	-8,669	-7,791		-22,692	-7,562	-8,264	-7,538	-7,522	-8,209	8,873	9,513	10,130	10,726	5,699	3,305	3,938	4,602	5,245	28,202	27,208	7,052
basic and diluted loss per common share															-90	-110	-70	-130	-80	-120	-57.5	-70	-60	-100	-102.5	-120	-140	-150			-150	-150			-0.07			-0.03						-0.01		-0.01	-0.02	-0.02					-0.11	-0.04	-0.05	-0.04	-0.03	-0.03		-0.01	-0.01	-0.01			-0.01	-0.01	-0.01	-0.01	-0.02	-0.03
operating expenses																				16,596,000	15,502,000	12,650,000	12,775,000	14,201,000	16,325,000	13,637,000	13,434,000	13,673,000		12,957,000	11,783,000	11,536,000		6,092,153	4,981,607	3,643,498		2,989,186	3,756,316	2,997,353		2,304,500	2,654,752	2,833,708		2,170,380	3,040,194	2,823,773	5,527,622	1,991,960	-802,592		11,358,610	4,752,146	3,820,574	2,887,856	2,864,152	2,415,708
nonoperating expense:
nonoperating expense																				-19,000	-13,750	-19,000	-24,000		-213,500	-314,000
other																											125,000				-65,000				745,773																																	-609.75	-3,077	222
basic and diluted weighted-average
common shares outstanding																					15,199,250	61,695,000	60,906,000		14,045,500	57,658,000
see notes to consolidated financial statements.
nonoperating expenses																														-9,000	-113,000	-44,000		-44,508	-45,286	-37,910		-10,827	-457,885	-187,701		-180,846	-131,132	-119,431		-12,219	-11,714	-9,251			-6,907		-19,967	-6,506	-7,065	-7,300	-7,227
loss from continuing operations																														-8,605,000	-8,050,000	-8,443,000		-3,221,292
loss from discontinued operations
gain on sale of discontinued operations																																		5,467,268
income from discontinued operations																																		5,358,369
basic earnings per common share:
earnings from discontinued operations																																		0.12
basic earnings per common share																														-160				0.05		-0.05				0.01
diluted earnings per common share:
diluted earnings per common share																														-160				0.04		-0.05				0.01
basic weighted-average common shares outstanding																														55,068,000				47,065,009		38,030,688				36,414,041											94,626,120
diluted weighted-average common shares outstanding																														55,068,000				47,556,697		38,030,688				37,472,579											97,924,457
basic and diluted loss per common share:
loss before taxes from discontinued operations																																		-108,899
provision for taxes																																						3,153	4,087	-10,740
loss on debt extinguishment																																							-313,099
loss before taxes																																			-2,764,124			-957,543	-86,754
income before income taxes																																				-1,928,755
see notes to condensed consolidated financial statements.
income before taxes																																								266,365
loss from investment in affiliate																																																21,543	11,680	33,281
basic and diluted net loss per common share																																																	-0.003	-0.01
gain on sale of assets																																																			-2,891,917
basic net income per common share																																																			0.02
diluted net income per common share																																																			0.01
nonoperating loss																																																										-7,779
basic and diluted average common shares outstanding																																																										65,001,979	62,944,298	4,058,664	60,118,183	43,623,403	28,838,216		28,838,216	28,838,216	28,838,216	3,038,050	28,600,943	24,755,583
nonoperating expenses:
basic and diluted income per common share																																																											-0.02
cost of goods sold																																																																699,292	953,043	865,071	979,054	899,783	881,839	832,905
selling																																																																157,842.75	190,153	219,596	221,622	210,539	178,439	159,558
operating expenses: - sum																																																																		764,560	788,265	907,347	885,534	991,932
nonoperating expenses: - sum																																																																		4,185	3,650	21,113	11,977	-4,276
income taxes

Balance Sheets:

Quarterly

Annual

Unit: USD	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-30	2017-09-30	2017-07-01	2017-04-01	2016-12-31	2016-10-01	2016-07-02	2016-04-02	2016-01-02	2015-10-03	2015-07-04	2015-04-04	2015-01-03	2015-01-02	2014-09-27	2014-06-28	2014-03-29	2013-12-28	2013-09-28	2013-06-29	2013-03-30	2012-12-29	2012-09-29	2012-06-30	2012-03-31	2011-12-31	2011-10-01	2011-09-30	2011-07-02	2011-04-02	2011-01-01	2010-10-02	2010-07-03	2010-04-03	2010-01-02	2010-01-01	2009-10-03	2009-07-04	2009-04-04	2009-01-03	2009-01-02	2008-09-27	2008-06-28	2008-01-03

assets
current assets
cash and cash equivalents, including restricted cash of 152 for both periods presented	64,788,000	64,290,000	60,474,000	55,616,000	44,660,000	32,398,000	27,885,000	27,565,000	27,325,000	26,773,000	26,406,000	23,141,000
trade receivables, net of allowance	9,741,000	8,506,000	9,656,000	7,052,000	7,768,000	7,096,000	7,818,000	6,604,000	5,234,000	5,601,000	6,118,000	9,221,000	8,482,000	4,744,000	4,228,000	6,310,000	5,226,000	5,295,000	5,999,000		2,694,000														4,579,253	5,044,877		6,511,439	6,793,779	4,330,115	2,450,591					2,450,591
inventories	20,424,000	18,791,000	14,406,000	11,185,000	9,192,000	10,544,000	11,511,000	12,495,000	14,525,000	12,624,000	11,973,000	11,908,000	14,677,000	15,636,000	15,753,000	15,307,000	13,601,000	12,676,000	12,183,000	12,762,000	11,683,000	11,031,000	12,338,000	11,280,000	11,535,000	9,820,000	10,714,000	8,670,000	8,249,000	7,079,000	6,526,000	5,063,000	5,796,281	6,615,245	7,794,182	8,938,099	7,912,630	6,312,909	4,524,803	6,688,920	8,173,799	4,163,628	3,089,033	3,231,696	3,734,341	8,173,799	2,286,086	2,873,028	2,492,777	2,204,125	2,217,698	1,944,597	1,573,452	5,205,304	5,436,439	5,253,797	4,050,895	2,905,600	2,500,798	2,500,798	1,974,530	1,306,290	1,423,035	1,468,323	1,164,657	987,579	922,760	1,423,035	889,150	848,425	792,889	711,584	922,760	627,214	578,505	711,584
assets held for sale	541,000
prepaid expenses and other assets	1,312,000	2,029,000	2,143,000	2,365,000	2,482,000	2,096,000	2,088,000	2,312,000	2,450,000	2,183,000	1,885,000	2,295,000	2,967,000	4,259,000	1,455,000	1,913,000	1,859,000	1,762,000	972,000	1,119,000	1,145,000	1,005,000	584,000	701,000	996,000	1,071,000	706,000	721,000	577,000	593,000	627,000	909,000	655,321	724,388	864,935	420,265	329,854	401,902	465,711	359,642	373,567	377,469	427,248	374,350	292,891	373,567	294,296	307,322	336,046	271,445	346,962	436,455	453,198	261,297	392,954	522,766	371,880	903,934	613,724	613,724	673,317	200,919	243,967	287,615	251,527	176,162	115,794	243,967					115,794
total current assets	96,806,000	93,616,000	86,679,000	76,218,000	64,102,000	52,134,000	49,302,000	48,976,000	49,534,000	47,181,000	46,382,000	46,565,000	46,567,000	37,901,000	38,508,000	44,523,000	48,905,000	52,835,000	57,932,000	63,219,000	32,219,000	30,728,000	35,766,000	29,147,000	33,518,000	36,365,000	37,525,000	34,777,000	36,534,000	41,487,000	46,485,000	52,582,000	57,178,318	36,259,034	27,376,977	15,588,594	15,736,943	15,491,006	15,154,512	14,374,183	16,547,629	13,034,280	12,314,764	9,056,338	9,898,691	16,547,629	6,312,778	6,582,138	6,420,802	5,790,699	4,677,703	6,267,720	5,690,003	7,927,140	8,269,893	8,977,774	11,628,611	4,953,352	5,832,662	5,832,662	5,534,574	5,641,236	4,895,024	5,325,874	5,643,538	2,470,933	2,007,860	4,895,024	1,998,093	1,936,460	2,187,277	2,298,749	2,007,860	3,738,426	3,611,559	2,298,749
leasehold improvements and equipment	1,323,000	1,499,000	1,632,000	1,655,000	1,719,000	1,718,000	1,841,000	2,000,000	2,137,000	2,293,000	2,501,000	2,689,000	2,799,000	2,791,000	2,899,000	2,940,000	3,003,000	3,084,000	3,150,000	3,058,000	3,206,000	3,307,000	3,487,000	3,613,000	3,765,000	3,696,000	3,737,000	3,714,000	3,585,000	3,745,000	3,878,000	2,911,000	2,871,886	2,690,527	3,372,879	3,252,514	3,111,374	2,495,215	1,860,476	1,722,768	1,788,645	1,581,961	1,552,250	1,579,994	1,264,660	1,788,645	1,293,702	1,218,351	1,025,690	1,063,239	969,755	1,012,963	980,792	936,426	987,732	1,066,661	1,140,487	1,172,288	1,182,453	1,182,453	1,240,184	1,279,839	1,303,108	1,360,362	1,395,917	1,450,033	1,203,431	1,303,108	1,123,506	1,178,129	1,237,197	1,294,062	1,203,431			1,294,062
intangible assets	5,660,000	246,000	284,000	322,000	359,000	397,000	435,000	472,000	510,000	552,000	591,000	630,000	671,000	714,000	758,000	808,000	857,000	908,000	961,000	1,022,000	1,082,000	1,147,000	1,189,000	1,249,000	1,311,000	1,373,000	1,434,000	1,496,000	1,547,000	1,521,000	1,536,000	1,593,000	1,651,407	1,709,609	1,767,811	1,833,781	486,226	495,936	510,637	357,741	354,052	371,325	298,020	290,937	296,061	354,052	266,824	255,937	199,017	201,650	188,363	165,561	171,218		140,829	95,307	98,715		248,012	248,012	256,005	259,488		296,437	315,019	333,601			352,447	383,404	414,360			478,027	430,124
right-of-use assets	2,192,000	2,361,000	2,525,000	2,684,000	1,730,000	1,899,000	2,063,000	2,226,000	2,400,000	3,003,000	3,179,000	3,352,000	3,523,000	3,714,000	3,884,000	4,053,000	4,352,000	3,049,000	3,182,000
other long-term assets	425,000	417,000	405,000	458,000	368,000	374,000	394,000	405,000	383,000	454,000	518,000	532,000	497,000	545,000	564,000	606,000	723,000	576,000	617,000	594,000	625,000	910,000	845,000	802,000	762,000	660,000	656,000	607,000	323,000
total assets	106,406,000	98,139,000	91,525,000	81,337,000	68,278,000	56,522,000	54,035,000	54,079,000	54,964,000	53,483,000	53,171,000	53,768,000	54,057,000	45,665,000	46,613,000	52,930,000	57,840,000	60,452,000	65,842,000	68,993,000	38,358,000	37,415,000	41,992,000	35,610,000	40,247,000	43,139,000	44,542,000	41,925,000	42,232,000	47,022,000	52,168,000	57,445,000	62,723,600	41,801,512	32,920,164	21,051,320	19,752,068	18,763,690	17,779,513	16,533,736	18,749,209	15,046,606	14,222,594	10,984,829	11,608,208	18,749,209	8,699,151	8,878,211	8,471,818	8,986,892	7,778,687	10,945,473	10,717,431	9,034,521	9,430,621	10,195,542	12,924,545	6,269,905	7,306,287	7,306,287	7,062,178
liabilities and stockholders' equity
current liabilities
accounts payable	10,796,000	12,742,000	13,680,000	10,632,000	8,526,000	6,903,000	8,105,000	7,899,000	10,232,000	9,198,000	10,031,000	8,951,000	9,679,000	9,119,000	10,197,000	9,780,000	10,423,000	10,804,000	9,970,000	11,693,000	9,445,000	6,881,000	9,780,000	8,159,000	9,626,000	6,168,000	9,323,000	9,753,000	9,548,000	8,893,000	6,757,000	5,856,000	3,718,407	4,346,700	3,131,759	7,865,099	5,978,288	4,098,778	2,331,376	2,905,105	6,223,958	3,560,569	3,094,543	2,640,950	3,451,608	6,223,958	2,270,645	2,758,264	1,922,069	1,440,910	2,347,222	2,152,023	2,376,208	3,428,233	2,838,988	3,401,382	3,066,456	2,250,241	1,306,547	1,306,547	1,357,006	980,643	514,598	815,604	786,942	878,605	548,310	514,598	473,576	486,303	498,201	444,337	548,310	388,996	547,455	444,337
accrued expenses	7,722,000	8,700,000	7,381,000	9,050,000	7,817,000	9,592,000	8,621,000	10,465,000	9,493,000	9,193,000	8,079,000	8,610,000	7,337,000	6,756,000	6,696,000	8,126,000	6,481,000	6,331,000	5,569,000	7,328,000	6,133,000	5,173,000	5,246,000	5,249,000	4,415,000	3,693,000	3,643,000	4,592,000	4,313,000	3,587,000	3,684,000	3,709,000	3,645,355	2,129,583	2,111,205	1,993,717	2,170,172	1,709,662	1,937,427	1,350,860	1,302,865	1,215,166	1,281,598	1,003,579	853,685	1,302,865	857,854	738,408	731,601	656,707	933,934	711,503	789,408	876,158	664,771	542,446	857,196	755,967	712,473	712,473	544,134	468,285	371,020	383,494	326,302	340,347	270,250	371,020	294,732	293,777	369,992	338,056	270,250	313,919	316,152	338,056
current maturities of operating lease obligations	1,002,000	976,000	957,000	939,000	982,000	1,008,000	973,000	850,000	691,000	854,000	775,000	697,000	680,000	684,000	646,000	630,000	528,000	447,000	467,000	485,000	589,000	650,000	632,000	614,000	595,000	620,000	662,000	675,000
current maturities of finance lease obligations		2,000	6,000	9,000	12,000	12,000	12,000	11,000	11,000	10,000	10,000	17,000	16,000	10,000	13,000	17,000	20,000	13,000	13,000	19,000	31,000	83,000	134,000	206,000	258,000	281,000	303,000	164,000
customer deposits	399,000	292,000	303,000	207,000	611,000	184,000	156,000	227,000	195,000	189,000	166,000	148,000	157,000	158,000	173,000	141,000	161,000	175,000	210,000	231,000	278,000	228,000	250,000	238,000
total current liabilities	19,919,000	22,712,000	22,327,000	20,837,000	17,948,000	17,699,000	17,867,000	19,452,000	20,622,000	19,444,000	19,061,000	18,423,000	17,869,000	16,727,000	17,725,000	18,694,000	17,613,000	17,770,000	16,229,000	19,756,000	16,476,000	13,015,000	16,042,000	14,466,000	15,063,000	11,023,000	24,211,000	15,547,000	14,440,000	12,960,000	10,956,000	10,084,000	8,087,934	7,209,188	6,260,018	10,744,926	8,869,150	6,356,097	4,788,131	6,707,340	9,586,621	5,880,865	5,032,147	4,771,908	4,980,820	9,586,621	3,582,022	3,980,114	3,236,384	2,838,134	4,110,673	3,362,475	3,645,697	4,762,959	3,900,573	4,253,702	4,284,236	3,343,000	2,389,583	2,389,583	2,193,318	1,777,918	1,139,286	1,363,625	1,257,967	2,577,895	2,151,714	1,139,286	2,170,034	2,073,128	2,162,957	2,073,331	2,151,714	2,968,318	3,127,226	2,073,331
deferred revenue	2,674,000	2,674,000	2,674,000	2,579,000	2,579,000	2,579,000	3,311,000	3,311,000	3,311,000	3,806,000	3,806,000	3,955,000	3,955,000	4,228,000	4,228,000	4,346,000	4,346,000	4,346,000	4,441,000	4,441,000	4,441,000	3,820,000	3,820,000	3,873,000	3,873,000	3,873,000	3,873,000	3,962,000
operating lease obligations, less current maturities	1,815,000	2,077,000	2,329,000	2,576,000	1,657,000	1,873,000	2,133,000	2,356,000	2,563,000	2,911,000	3,137,000	3,353,000	3,539,000	3,687,000	3,882,000	4,013,000	4,154,000	2,876,000	3,017,000	947,000	997,000	1,070,000	522,000	687,000	848,000	1,031,000	1,192,000	1,345,000
deferred consideration liability	5,465,000
total liabilities	29,873,000	27,463,000	27,330,000	25,992,000	22,184,000	22,153,000	23,317,000	25,128,000	26,508,000	26,175,000	26,021,000	25,751,000	25,385,000	24,642,000	25,835,000	27,053,000	26,113,000	25,003,000	23,700,000	25,161,000	21,934,000	17,928,000	20,411,000	19,062,000	19,802,000	15,997,000	29,397,000	20,948,000	15,054,000	13,620,000	11,668,000	10,781,000	8,889,932	8,063,671	7,200,741	11,679,262	9,777,710	6,906,336	5,331,860	10,105,530	13,474,535	10,710,868	10,326,132	7,296,044	7,609,817	13,474,535	4,195,770	4,559,691	3,677,340	3,321,441
commitments and contingencies
stockholders' equity
common stock, 0.001 par value...	79,000	79,000	79,000	78,000	77,000	76,000	75,000	75,000	75,000	75,000	75,000	74,000	74,000	68,000	68,000	68,000	68,000	68,000	68,000
additional paid-in capital	240,991,000	239,266,000	237,358,000	232,119,000	227,931,000	223,389,000	221,612,000	219,829,000	218,845,000	217,808,000	216,691,000	215,367,000	214,094,000	205,027,000	203,798,000	202,502,000	200,614,000	199,011,000	196,848,000	192,972,000	158,190,000	155,156,000	153,036,000	144,290,000	142,285,000	140,130,000	120,935,000	119,012,000	116,876,000	114,882,000	113,375,000	111,489,000	110,380,163	81,469,567	75,590,304	56,486,469	55,160,387	54,896,632	54,532,594	48,431,789	47,462,052	45,098,163	44,655,200	44,132,635	43,417,442	47,462,052	42,695,089	41,851,099	40,674,072	39,697,063	36,579,826	36,329,257	34,886,353	33,617,801	33,155,460	31,993,120	30,663,492	20,542,532	20,043,209	20,043,209	17,569,826	16,268,601	15,034,550	14,329,414	13,895,200	9,177,740	9,126,141	15,034,550	9,074,022	9,018,075	8,967,245	8,920,283	9,126,141	8,868,565	7,826,686	8,920,283
accumulated deficit	-164,528,000	-168,660,000	-173,238,000	-176,847,000	-181,910,000	-189,089,000	-190,967,000	-190,952,000	-190,460,000	-190,574,000	-189,615,000	-187,424,000	-185,493,000	-184,075,000	-183,090,000	-176,693,000	-168,953,000	-163,628,000	-154,772,000	-149,206,000	-141,825,000	-135,728,000	-131,513,000	-127,802,000	-121,900,000	-113,047,000	-105,845,000	-98,090,000	-89,753,000	-81,535,000	-72,930,000	-64,880,000	-56,601,192	-47,779,376	-49,916,453	-47,152,329	-45,223,574	-43,076,821	-42,122,431	-42,039,764	-42,295,389	-40,868,745	-40,865,029	-40,549,837	-39,524,322	-42,295,389	-38,296,948	-37,637,295	-35,984,153	-34,136,137	-33,411,813	-29,237,809	-28,248,087	-29,716,612	-28,018,030	-26,479,996	-22,486,039	-18,054,186	-15,563,068	-15,563,068	-13,158,156	-11,315,587	-10,159,202	-9,260,536	-8,377,313	-8,073,784	-8,107,526	-10,159,202	-7,992,444	-7,814,900	-7,523,800	-7,199,958	-8,107,526	-6,550,410	-5,840,062	-7,199,958
cumulative translation adjustments	-9,000	-9,000	-4,000	-5,000	-4,000	-7,000	-2,000	-1,000	-4,000	-1,000	-1,000		-3,000	3,000	2,000		-2,000	-2,000	-2,000	-2,000	-3,000	-3,000	-3,000
total stockholders' equity	76,533,000	70,676,000	64,195,000	55,345,000	46,094,000	34,369,000	30,718,000	28,951,000	28,456,000	27,308,000	27,150,000	28,017,000	28,672,000	21,023,000	20,778,000	25,877,000	31,727,000	35,449,000	42,142,000	43,832,000		19,487,000	21,581,000	16,548,000	20,445,000	27,142,000	15,145,000	20,977,000	27,178,000	33,402,000	40,500,000	46,664,000	53,833,668	33,737,841	25,719,423	9,372,058	9,974,358	11,857,354	12,447,653	6,428,206	5,274,674	4,335,738	3,896,462	3,688,785	3,998,391	5,274,674	4,503,381	4,318,520	4,794,478	5,665,451	3,268,833	7,192,255	6,734,274	3,993,329	5,229,080	5,603,438	8,265,658	2,561,286	4,553,081	4,553,081	4,477,388
total liabilities and stockholders' equity	106,406,000	98,139,000	91,525,000	81,337,000	68,278,000	56,522,000	54,035,000	54,079,000	54,964,000	53,483,000	53,171,000	53,768,000	54,057,000	45,665,000	46,613,000	52,930,000	57,840,000	60,452,000	65,842,000	68,993,000		37,415,000	41,992,000	35,610,000	40,247,000	43,139,000	44,542,000	41,925,000	42,232,000	47,022,000	52,168,000	57,445,000	62,723,600	41,801,512	32,920,164	21,051,320	19,752,068	18,763,690	17,779,513	16,533,736	18,749,209	15,046,606	14,222,594	10,984,829	11,608,208	18,749,209	8,699,151	8,878,211	8,471,818	8,986,892	7,778,687	10,945,473	10,717,431	9,034,521	9,430,621	10,195,542	12,924,545	6,269,905	7,306,287	7,306,287	7,062,178
finance lease obligations, less current maturities						2,000	6,000	9,000	12,000	14,000	17,000	20,000	22,000					11,000	13,000	17,000	20,000	23,000	27,000	36,000	18,000	70,000	121,000	94,000
cash and cash equivalents, including restricted cash of 0.2 million for both periods presented													20,441,000				28,219,000
cash and cash equivalents, including restricted cash of 0.2 million as of both dates														13,262,000	17,072,000
cash, including restricted cash of 0.2 million as of both dates																20,993,000
cash, including restricted cash of 0.2 million for both periods																		33,102,000	38,778,000
cash, including restricted cash of 0.2 million and 0.2 million, respectively																				44,691,000	16,697,000	15,478,000	18,890,000	13,608,000	18,812,000	18,879,000	19,760,000	19,327,000
receivables from related party: 1.3 million and 0.9 million, respectively																				4,647,000
right of use assets																				1,100,000	1,226,000	1,323,000	705,000	799,000	891,000	1,045,000	1,190,000
common stock, .001 par value...																				68,000	62,000																										105,240	104,716		104,525	100,820	100,807	96,008	92,140	91,650		88,205	72,940	72,940	72,940	65,718		60,875	60,161	60,111	28,838	28,838	60,875	28,838	28,838	28,838	28,838	28,838	28,830	28,022	28,838
liabilities and stockholders’ equity
stockholders’ equity
total stockholders’ equity																					16,424,000
total liabilities and stockholders’ equity																					38,358,000
receivables from related party: 1.0 million and 0.8 million, respectively																						3,214,000
common stock
issued and outstanding september 30, 2020 61,587 shares and
december 31, 2019 59,562 shares																						62,000	61,000	60,000
receivables from related party: 1.1 million and 0.8 million, respectively																							3,954,000
issued and outstanding june 30, 2020 61,421 shares and
receivables from related party: 0.5 million and 0.8 million, respectively																								3,558,000
issued and outstanding march 31, 2020 59,605 shares and
receivables from related party: 0.8 million and 0.7 million, respectively																									2,175,000
contract assets																										89,000	52,000	72,000	56,000	76,000	62,000	53,000
receivable held at escrow, net of allowance of 0.1 million																												677,000	677,000
contract liabilities and customer deposits																									169,000	261,000	293,000	363,000	275,000	155,000	185,000	202,000
deferred rent																																																																303,476	312,001	318,082	319,973		173,579	173,881	177,665	186,323	319,973	142,330	147,888	186,323
issued and outstanding december 31, 2019 59,562 shares and
december 31, 2018 55,089 shares																									60,000	59,000	55,000	55,000
receivables from related party: 1.9 million and 0.7 million, respectively																										5,953,000
receivable held at escrow, net of allowance of 0.2 million and 0.1 million, repectively																										553,000	553,000
issued and outstanding september 30, 2019 59,383 shares and
receivables from related party: 1.6 million and 0.7 million, respectively																											5,740,000
convertible notes																											9,987,000
issued and outstanding june 30, 2019 55,384 shares and
receivables from related party: 1.0 million and 0.7 million, respectively																												5,310,000
right of use																												1,331,000
deferred rent, current																													131,000	142,000	139,000	117,000	114,304	120,894	114,101	111,879	76,219	52,734	38,350	26,143	39,529	52,914	66,299	73,942	69,456	39,529	65,040	60,531	57,600	55,586	56,026	51,743	66,772	71,042	67,206	63,370	59,553	59,743	59,933	59,933	59,076	58,246	62,664					62,664
deferred rent, less current																													477,000	482,000	493,000	439,000	491,909	493,735	547,539	568,943	564,971	267,419	205,826	92,519	97,990	103,461	108,933	118,651	137,508	97,990	156,779	175,496	191,163	202,965	190,536	152,456	118,508	129,859	148,544	167,229	185,269	200,890	215,739	215,739	226,573	236,294	233,822					233,822
issued and outstanding march 31, 2019 55,321 shares and
see notes to consolidated financial statements.
cash, including restricted cash of 0.2 million and 0, respectively																													22,616,000
receivables from related party: 0.7 million and 1.0 million, respectively																													4,359,000
deposits																													243,000	269,000	269,000	359,000	271,631	392,342	402,497	376,431	397,207		233,570	58,726	58,883	59,040	57,560	57,560		58,883	52,046	47,984	52,508	43,460	43,343	41,192	35,424	34,773	32,167	55,800	56,732	44,159	43,160	43,160	31,415	31,415	31,415	32,227	32,227	32,227	32,227	31,415	33,392	41,682	41,682	44,981	32,227	41,682	49,821	44,981
receivable held at escrow																														752,000	751,000	750,000	750,358	750,000
current maturities of capital lease obligations																													173,000	183,000	191,000	200,000	195,533	190,892	299,103	275,221	255,461	217,308	218,126	218,919	219,689	216,551	211,932	207,413	148,278	219,689	162,566	159,641	136,090	138,887	113,846	110,382	98,841	77,259	72,604	76,892	81,229	77,356	70,876	70,876	73,835	76,460	78,577	75,875	73,268	70,750	28,430	78,577	36,979	51,182	65,010	78,472	28,430	81,902	79,378	78,472
due to officer																																	100,000	100,000	100,000	100,000
capital lease obligations, less current maturities																													137,000	178,000	219,000	258,000	310,089	360,748	393,184	365,393	343,589	282,820	337,903	391,817	444,589	500,128	556,029	610,738	423,015	444,589	456,969	404,081	249,793	280,342	208,645	238,287	218,952	148,374	152,424	171,173	189,382	164,729	147,884	147,884	164,899	181,562	198,071	218,760	238,735	258,023	45,868	198,071	53,409	60,653	67,611	74,293	45,868	90,387	111,835	74,293
issued and outstanding december 31, 2018 55,089 shares and
december 30, 2017 54,697 shares																													55,000	55,000	55,000	55,000
cash																														28,214,000	33,389,000	41,037,000	45,388,848	23,999,633	14,138,607	1,185,353	1,642,429	2,264,756	3,370,219	2,995,506	5,549,672	4,708,642	5,699,248	3,215,839	3,964,750	5,549,672	1,203,758	1,280,627	1,924,538	2,261,336	1,087,424	826,631	966,576	520,000	1,237,071	2,213,009	5,805,179	420,152	2,069,308	2,069,308	2,044,848	2,895,777	2,226,459	2,985,632	3,381,744	538,675	471,378	2,226,459	501,425	606,575	842,988	1,125,504	471,378		2,415,620	1,125,504
receivables from related party: 0.7 million and 1.5 million, respectively																														4,773,000
issued and outstanding september 30, 2018 54,919 shares and
receivables from related party: 0.9 million and 1.5 million, respectively																															5,130,000
issued and outstanding june 30, 2018 54,870 shares and
receivables from related party: 0.8 million and 1.5 million, respectively																																4,770,000
issued and outstanding march 31, 2018 54,681 shares and
receivables from related party: 1.0 million and 0, respectively																																	5,337,868
current assets held for sale
long-term investment, related party																																					20,318
noncurrent assets held for sale
customer deposits and other																																	314,335	321,119	503,850	399,010	389,010	277,615	262,852	339,600	272,002	236,828	229,184	393,352	234,435	272,002	225,917	263,270	389,024	546,044	659,645	336,824	314,468	310,267	257,004	169,612	219,802	199,693	239,754	239,754	159,267	194,284	112,427	88,652	71,455	109,987	126,518	112,427	186,541	63,660	51,548	34,260	126,518	24,938	46,418	34,260
noncurrent liabilities held for sale
issued and outstanding 2017 54,696,741 shares and 2016 37,544,531 shares																																	54,697
receivables from related party: 1.5 million and 0, respectively																																		4,919,768
longterm investment																																						20,318	20,318	20,318
issued and outstanding september 30, 2017 47,650,252 shares and
december 31, 2016 37,544,531 shares																																		47,650	45,572	37,918
issued and outstanding july 1, 2017 45,571,891 shares and
issued and outstanding april 1, 2017 37,918,048 shares and
trade receivables																																					5,852,030																								841,879	1,238,250		584,304	845,610	768,517			499,727	418,659	454,370			532,351	504,351
current maturities of loan payable																																								1,866,713	1,528,578	598,837	148,591	452,672	223,358	1,528,578
loan payable, less current maturities																																								2,913,854	3,345,335	4,226,414	4,629,023	1,794,747	2,068,474	3,345,335
issued and outstanding 2016 37,544,531 and 2015 36,003,589 shares																																					37,545
deposits and other																																						261,215							148,796
issued and outstanding october 1, 2016 37,543,198 and
january 2, 2016 36,003,589 shares																																						37,543
see notes to condensed consolidated financial statements.
july 2, 2016 37,489,914 and january 2, 2016 36,003,589 shares																																							37,490
issued and outstanding april 2, 2016 36,180,849 and january 2, 2016 36,003,589 shares																																								36,181
issued and outstanding 2015 108,010,766 and 2014 105,271,058 shares																																									108,011					108,011
trade receivables, less allowance for doubtful accounts and returns
october 3, 2015 43,000; january 3, 2015 38,000																																										3,784,541
issued and outstanding october 3, 2015 106,319,606 and
january 3, 2015 105,271,058 shares																																										106,320	106,291	105,987
trade receivables, less allowance for doubtful accounts and returns july 4, 2015 41,000; january 3, 2015 38,000																																											3,099,235
issued and outstanding july 4, 2015 106,290,803 and
april 4, 2015 51,000; january 3, 2015 38,000																																												2,234,453
other noncurrent assets
total other noncurrent assets																																												348,497	444,857		1,092,671	1,077,722	1,025,326	2,132,954	2,131,229	3,664,790	4,046,636
issued and outstanding april 4, 2015 105,987,058 and
trade receivables, less allowance for doubtful accounts and returns 2014 38,000; 2013 9,000																																													1,906,709
other receivable																																																		215,000
long-term investment in affiliate																																															773,801	773,801	773,801	1,887,844	1,899,523
issued and outstanding 2014 105,271,058 and 2013 104,524,738 shares																																													105,271
trade receivables, less allowance for doubtful accounts and returns september 27, 2014 33,000; december 28, 2013 9,000																																															2,528,638
june 28, 2014 25,000; december 28, 2013 9,000																																																2,121,161
march 29, 2014 16,000; december 28, 2013 9,000																																																	1,667,441
issued and outstanding march 29, 2014 104,559,101 and
december 28, 2013 104,524,738 shares																																																	104,559
trade receivables, less allowance for doubtful accounts and returns 2013 9,000; 2012 450,000																																																		838,793
trade receivables, less allowance for doubtful accounts and returns september 28, 2013 10,000; december 29, 2012 450,000																																																			1,025,619
trade receivables, less allowance for doubtful accounts and returns june 29, 2013 17,000; december 29, 2012 450,000																																																				1,186,529
non-trade receivable																																																				250,000	500,000
note receivable, current																																																				1,623,508	1,210,407
note receivable, less current																																																				779,205	1,161,162
long-term equity investment																																																				2,678,832	2,678,832
trade receivables, less allowance for doubtful accounts and returns march 30, 2013 18,000; december 29, 2012 450,000																																																					986,370
trade receivables, less allowance for doubtful accounts and returns 2012 450,000; 2011 9,000																																																						1,940,539
deposits and other noncurrent assets
intangible assets, less accumulated amortization 2012 850,103; 2011 834,169																																																						136,182
total deposits and other noncurrent assets																																																						170,955	172,996	151,107	155,447	144,265	291,172	291,172	287,420
trade receivables, less allowance for doubtful accounts and returns september 29, 2012 920,000; december 31, 2011 9,000																																																							1,203,429
trade receivables, less allowance for doubtful accounts
june 30, 2012 15,000; december 31, 2011 9,000																																																								988,202
issued and outstanding june 30, 2012 90,313,834 shares;
december 31, 2011 72,939,996 shares																																																								90,314
trade receivables, less allowance for doubtful accounts march 31, 2012 12,000; december 31, 2011 9,000																																																									1,400,657
trade receivables, less allowance for doubtful accounts 2011 9,000; 2010 18,000																																																										723,666
intangible assets, less accumulated amortization 2011 834,169; 2010 990,420																																																										100,106
trade receivables, less allowance for doubtful accounts october 1, 2011 14,000; january 1, 2011 18,000																																																											648,832	648,832
outstanding april 2, 2011 63,190,183 shares; january 1, 2011 60,875,325 shares																																																														63,190
trade receivables, less allowance for doubtful accounts 2010 18,000; 2009 16,000																																																															1,001,563					1,001,563
intangible assets, less accumulated amortization 2010 990,420; 2009 916,785																																																															277,855					277,855
due to officers																																																																		1,178,206	1,178,206		1,178,206	1,178,206	1,178,206	1,178,206	1,178,206	1,178,206	1,178,206	1,178,206
trade receivables, less allowance for doubtful accounts 2009 16,000; 2008 11,000																																																																			497,928						497,928
intangible assets, less accumulated amortization 2009 916,785; 2008 792,957																																																																			321,490						321,490
prepaid expenses and other																																																																					107,791	62,801	97,030	112,609		158,611	113,083	112,609
deposits and other noncurrent assets - sum																																																																						425,086	456,042	490,299		519,709	479,945
stockholders’ equity - sum																																																																						1,232,013	1,472,283	1,749,163		2,346,985	2,014,646
trade receivables, less allowance for doubtful accounts 2008 11,000; 2007 70,000																																																																								349,052				349,052
intangible assets, less accumulated amortization 2008 792,957; 2007 672,970																																																																								445,318				445,318
cash and cash equivalents																																																																										2,420,250
property and equipment																																																																										1,289,885	1,310,091
notes payable																																																																										980,357	959,617

Cashflow Statements:

Quarterly

Annual

Unit: USD	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-30	2017-09-30	2011-04-02	2010-10-02	2010-07-03	2010-04-03	2009-10-03	2009-07-04	2009-04-04	2009-01-03

cash flows from operating activities
net income	4,132,000	4,578,000	3,609,000	5,063,000	7,179,000														-8,337,000	-8,218,000	-8,605,000	-8,050,000	-8,443,000	-8,821,816	2,137,077	-1,156,385	-883,223	-303,529	33,742	-177,545	-291,100	-323,842
adjustments to reconcile net income to net cash from operating activities:
depreciation of leasehold improvements and equipment	139,000	157,000	158,000	158,000	151,000	164,000	170,000	178,000	177,000	233,000	232,000	228,000	221,000	235,000	212,000	201,000	211,000	232,000	173,000	171,000	169,000	146,000	121,000	113,933	131,765
amortization of intangibles	60,000	38,000	38,000	37,000	38,000	38,000	37,000	38,000	39,000	39,000	39,000	41,000	43,000	44,000	50,000	49,000	51,000	53,000	61,000	60,000	59,000	58,000	58,000	58,203	58,202	18,367	18,582	18,582	17,889	30,957	30,956	30,958
noncash lease expense	169,000	164,000	159,000	173,000
share-based compensation expense	1,748,000	1,756,000	1,488,000	1,075,000	752,000	735,000	1,185,000	984,000	1,037,000	1,117,000	1,324,000	1,273,000	1,326,000	1,229,000	1,296,000	1,888,000	1,473,000	1,822,000	2,029,000	1,985,000	1,317,000	1,811,000	1,258,000	3,394,241	490,817	737,019	423,764	230,858	51,599
loss on sale or disposal of leasehold improvements and equipment
allowance for (recovery of) credit losses
reversal of previously accrued royalties and license maintenance fees
gain on settlement of royalty obligation
interest accretion on deferred consideration
non-cash financing costs	18,000	15,000	13,000	13,000	18,000	21,000	20,000	21,000	15,000	18,000	21,000	21,000	13,000	20,000	16,000	18,000	21,000	30,000		0	0	38,000	32,000	31,278	32,894
changes in operating assets and liabilities:
trade receivables	-1,262,000	1,162,000	-2,693,000	2,037,000	642,000	710,000	-1,226,000	-1,405,000	348,000	323,000	2,668,000	-1,084,000	-3,773,000	-522,000	2,070,000	-1,094,000	-130,000	883,000	-956,000	414,000	362,000	-344,000	679,000	-554,436	-136,759	-236,687	261,306	-77,093	-270,589
inventories	-2,036,000	-4,385,000	-3,221,000	-1,993,000	1,352,000	967,000	984,000	2,030,000	-1,901,000	-651,000	-65,000	2,769,000	959,000	117,000	-446,000	-1,706,000	-926,000	-492,000	-421,000	-1,171,000	-552,000	-1,463,000	733,000	818,964	1,178,937	116,745	-303,666	-177,078	-64,819	-40,725	-55,536	-81,305
implementation costs for cloud computing arrangement	0	0	0	-66,000					0	0	-33,000	-27,000	-23,000	-77,000	-90,000	-114,000	-128,000	-71,000
prepaid expenses and other assets	746,000	87,000	268,000	20,000	-357,000	-9,000	215,000	106,000	-136,000	-252,000	403,000	616,000	1,389,000	-2,790,000	483,000	46,000	-202,000	-779,000	-140,000	118,000	32,000	282,000	-367,000	184,041	74,326	43,048	-36,088	-75,365	-60,368
accounts payable	-1,946,000	-938,000	3,048,000	2,106,000	2,262,000	-1,202,000	206,000	-2,333,000	1,034,000	-833,000	1,080,000	-728,000	560,000	-1,078,000	417,000	-643,000	-381,000	834,000	206,000	655,000	2,136,000	900,000	2,138,000	-628,292	1,214,941	466,045	28,662	-91,663	330,295	-12,727	-11,898	53,864
accrued expenses	958,000	1,319,000	-1,669,000	1,233,000	1,107,000	971,000	-1,844,000	972,000	300,000	1,114,000	-531,000	1,273,000	581,000	60,000	-1,430,000	1,645,000	150,000	762,000	279,000	726,000	-97,000	-25,000	64,000	1,515,772	18,378	97,265	57,192	-14,045	70,097	956	-76,215	31,936
deferred revenue	0	0			0				-495,000	0			-273,000	0			0		3,962,000
customer deposits and other	107,000	-16,000	97,000	-405,000	430,000	23,000	-72,000	35,000	3,000	24,000	17,000	-6,000	-7,000	-14,000	34,000	-18,000	-13,000	-35,000	88,000	119,000	-29,000	-17,000	-4,000	-6,784	-175,911	81,857	17,197	-38,532	-16,531	122,881	12,112	17,288
operating lease liabilities	-236,000	-233,000	-229,000	-251,000	-242,000	-225,000	-100,000	-48,000	-65,000	-147,000	-138,000	-169,000	-152,000	-157,000	-115,000	-39,000
net cash from operating activities	679,000	3,692,000	1,250,000	7,883,000	8,583,000	3,495,000	-264,000	295,000	649,000	396,000	3,280,000	2,792,000	-328,000	-3,740,000	-3,832,000	-7,198,000	-4,944,000	-5,919,000	-3,048,000	-5,136,000	-5,235,000	-6,548,000	-3,989,000	-3,766,977	-475,321	247,290			164,057
capital expenditures	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0			0
free cash flows	679,000	3,692,000	1,250,000	7,883,000	8,583,000	3,495,000	-264,000	295,000	649,000	396,000	3,280,000	2,792,000	-328,000	-3,740,000	-3,832,000	-7,198,000	-4,944,000	-5,919,000	-3,048,000	-5,136,000	-5,235,000	-6,548,000	-3,989,000	-3,766,977	-475,321	247,290			164,057
cash flows from investing activities
purchases of leasehold improvements and equipment	-101,000	-24,000	-135,000	-32,000	-69,000	-41,000	-12,000	-41,000	-21,000	-26,000	-10,000	-91,000	-172,000	-52,000	-85,000	-25,000	-2,000	-96,000	-239,000	-10,000	-37,000	-1,113,000	-161,000	-295,291	-577,137	-58,693	-45,311	-23,171	-56,277	-11,585	-14,263	-11,061
proceeds from the sale of leasehold improvements and equipment					0				0	0
net cash from investing activities	-101,000	-24,000	-135,000	-32,000	-69,000	-21,000	-12,000	-41,000	-21,000	-26,000	-5,000	-91,000	-172,000	-52,000	-85,000	-25,000	-2,000	-96,000	-296,000	-419,000	-82,000	-1,113,000	-161,000	-295,291	5,376,253
cash flows from financing activities
proceeds from exercise of stock options	228,000	152,000	3,752,000	3,114,000	3,791,000	1,043,000											130,000	341,000	107,000	9,000	190,000	75,000	255,000	2,642,946	383,048	19,348
repurchase of common stock																				0	0	0	-404,000
payment of debt issuance costs	-55,000	0	-6,000	-6,000	-41,000	0	0	-11,000					-62,000				-63,000	0		0	0	-13,000	-6,000	-25,899	-7,000
principal payments on finance leases	-2,000	-4,000	-3,000	-3,000	-2,000	-4,000	-2,000	-3,000	-1,000	-3,000	-10,000	-1,000	-6,000	-3,000	-4,000	-3,000	-4,000	-2,000
net cash from financing activities	-80,000	148,000	3,743,000	3,105,000	3,748,000	1,039,000	596,000	-14,000	-76,000	-3,000	-10,000	-1,000	7,679,000	-18,000	-4,000	-3,000	63,000	339,000	55,000	-43,000	142,000	13,000	-202,000	25,451,483	4,960,094	480,721	-6,868			-21,447	-20,786	-20,144
net increase in cash and cash equivalents	498,000	3,816,000	4,858,000	10,956,000	12,262,000	4,513,000	320,000	240,000	552,000	367,000	3,265,000	2,700,000	7,179,000	-3,810,000
cash and cash equivalents, including restricted cash of 152 for both periods - beginning of year
cash and cash equivalents, including restricted cash of 152 for both periods - end of year
supplemental disclosures of cash flow information
cash payments for interest on finance leases																	0	0
cash payments for principal on operating lease liabilities	236,000	233,000	109,000	295,000	242,000	135,000	132,000	91,000	102,000	166,000	162,000	180,000	135,000	168,000	146,000	58,000
supplemental schedule of noncash operating activity
right-of-use assets and operating lease obligations incurred for entering into lease amendment	0	0	0	1,127,000													1,428,000	0
supplemental schedule of noncash investing activity
acquisition of patent intangible asset and deferred consideration liability
loss on disposal of leasehold improvements and equipment		0	0	4,000						0			0	2,000
(recovery of) / allowance for credit losses		-12,000	89,000	-1,321,000
cash and cash equivalents, including restricted cash of 152 for both periods - beginning of period		0	0	44,660,000		0	0	27,325,000		0	0	20,441,000
cash and cash equivalents, including restricted cash of 152 for both periods - end of period		3,816,000	4,858,000	55,616,000		4,513,000	320,000	27,565,000		367,000	3,265,000	23,141,000
gain on sale or disposal of leasehold improvements and equipment
loss from impairment of intangibles
adjustment to retained earnings, cumulative effect of initially adopting asc 326									0	0	0	29,000
right-of-use assets and operating lease obligations reduced for entering into lease amendment
amortization of right of use assets						164,000	163,000	174,000	157,000	176,000	173,000	171,000	191,000	170,000	169,000	299,000	126,000	131,000	138,000
gain on disposal of leasehold improvements and equipment
allowance for credit losses						12,000	12,000	35,000
net loss							-15,000	-492,000	114,000	-959,000	-2,191,000	-1,902,000			-6,397,000	-7,740,000
adjustments to reconcile net loss to net cash from operating activities:
provision for doubtful trade receivables									19,000	194,000	435,000	316,000			12,000	10,000
proceeds from issuance of common stock																	0	0									0
financing lease obligation incurred for computer equipment and software
cash and cash equivalents, including restricted cash of 0.2 million for both 2022 and 2021 - beginning of year
cash and cash equivalents, including restricted cash of 0.2 million for both 2022 and 2021 - end of year
benefit from doubtful trade receivables
cash and cash equivalents, including restricted cash of 0.2 million for both periods - beginning of period														0
cash and cash equivalents, including restricted cash of 0.2 million for both periods - end of period														-3,810,000
net increase in cash																-7,226,000		-5,676,000		-5,598,000	-5,175,000			21,389,215	9,861,026	669,318	-396,112	2,843,069	67,297	-105,150	-236,413	-282,516
cash, including restricted cash of 0.2 million for both periods - beginning of period																28,219,000
cash, including restricted cash of 0.2 million for both periods - end of period																20,993,000
loss from investment in long-term assets
principal payments on operating leases																	-69,000	-160,000	-119,000
purchases of intangible assets																			-10,000	-86,000				0	0
investment in other long-term assets																			-47,000
cash and cash equivalents, including restricted cash of 0.2 million for both 2021 and 2020 - beginning of period
cash and cash equivalents, including restricted cash of 0.2 million for both 2021 and 2020 - end of period
financing lease obligation incurred for purchase of computer equipment and software
retirement of fully depreciated equipment - cost																								1,477	0
retirement of fully depreciated equipment - accumulated depreciation																								-1,477	0
change in allowance for doubtful trade receivables																		-178,000
cash, including restricted cash of 0.2 million for both 2021 and 2020 - beginning of period																		0
cash, including restricted cash of 0.2 million for both 2021 and 2020 - end of period																		-5,676,000
allowance for doubtful trade receivables																			5,000	0	-5,000	-15,000	-112,000	136,336	-203,756
cash beginning of period, including restricted cash of 0.2 million for both 2021 and 2020
cash ending of period, including restricted cash 0.2 million for both 2021 and 2020
share-based compensation
income from investment in long-term assets
income from impairment of intangibles
income from disposal of equipment																				0	0	0	1,000	0	3,197
amortization of convertible notes issuance costs and discount
payments on operating leases
proceeds from disposal of assets held at escrow
proceeds from sale of convertible notes
payment of convertible notes issuance costs
net decrease in cash																			-3,289,000				-4,352,000
cash beginning of year, including restricted cash of 0.2 million for both 2020 and 2019
cash ending of year, including restricted cash of 0.2 million for both 2020 and 2019
finance lease obligation incurred on licensing fees
right of use assets transferred
operating lease obligation transferred
operating lease obligation incurred for entering into lease amendment
finance lease obligation incurred for purchase of computer equipment and software
operating lease obligation incurred for tenant improvement credit received
supplemental schedule of noncash financing activity
issuance of common stock for conversion of debt and accrued interest
amortization of convertible notes issuance costs
cash beginning of period, including restricted cash of 0.2 million for both 2020 and 2019
cash ending of period, including restricted cash 0.2 million for both 2020 and 2019
financing lease obligation incurred for prepayment of licensing fees
contract assets																			-16,000		-14,000	-10,000	3,000
financing lease obligation incurred for purchase of computer equipment
other non-cash expense																				0	0
deferred rent																				-16,000	-8,000	76,000	-50,000	-8,417	167,839	-1,946	-8,525	-6,081	-1,891	-302	-3,784	-8,658
due to officer																				0	0	0	-100,000	0	0
cash beginning of year, including restricted cash of 0.2 million for 2019
cash ending of year, including restricted cash of 0.2 million for both 2019 and 2018
adjustment to retained earnings - cumulative effect of initially applying asc 606																				0	0	0	164,000
finance lease obligation incurred for purchase of software
amortization of covertible notes issuance costs and discount
cash beginning of period, including restricted cash of 0.2 million for 2019																			22,616,000
cash ending of period, including restricted cash 0.2 million for 2019																			19,327,000
financing lease obligation incurred for licensing fees
financing lease obligation incurred for purchase of software
amortization of covertible notes issuance costs
principal payments on capital leases																			-52,000	-52,000	-48,000	-49,000	-47,000	-46,018	-423,432	-18,626	-17,368	-16,770	-10,483	-21,447	-20,786	-20,144
cash payments for interest																			7,000	8,000	11,000	10,000	12,000	13,112	17,301	8,873	10,130	10,726	5,699	3,938	4,602	5,245
operating lease obligation incurred for tenant improvement credit from landlord																			64,000
see notes to consolidated financial statements.
gain from disposal of assets																								0
proceeds from disposal of assets, net of transaction costs																								0
proceeds from issuance of common stock, net of issuance costs																								22,880,454	5,007,478
cash beginning of year
cash ending of year, including restricted cash 0.2 million for 2018
noncash consideration transferred for the acquisition of healthspan research llc																								0	0
capital lease obligation incurred for the purchase of equipment																								0	282,785		0	0	264,958
receivable from disposal of assets held at escrow																								0
cash beginning of period																					0	0	45,389,000		0
cash ending of period																					-5,175,000	-7,648,000	41,037,000		9,861,026
basic weighted-average common shares outstanding :																									4,943,859
basic earnings per common share																									0.12
dilutive effect of stock options
dilutive effect of warrants
diluted weighted-average common shares outstanding :																									5,435,547
diluted earnings per common share																									0.11
potentially dilutive securities, total :
stock options																					-23,000	1,038,000	7,521,000		-516,620
warrants																					0	0	470,000		-17,952
basic and diluted loss per common share																						0	-150
basic and diluted weighted-average
common shares outstanding :
potentially dilutive securities :
includes approximately 0.2 million weighted-average nonvested shares of restricted for the three and six month periods ending june 30, 2018, respectively, and approximately 0.5 million nonvested shares of restricted stock for the three and six month periods ending july 1, 2017, respectively. these shares are participating securities that feature voting and dividend rights.
excluded from the computation of loss per share as their impact is antidilutive.
basic and diluted weighted-average common shares outstanding:																							54,858,000
loss on debt extinguishment
proceeds from loan payable
principal payment on loan payable
cash paid for debt extinguishment costs
cash ending of year
inventory supplied to healthspan research, llc for equity interest, at cost
note 1.
cash paid for debt extinguisment costs
inventory supplied to healthspan research llc for equity interest, at cost
non-cash loss on debt extinguishment
bulk ingredients
reference standards
dietary supplement bottles - dtc
less valuation allowance
income from investment in affiliate
other receivable
proceeds from sales of equipment
proceeds from investment in affiliate
stock issued to settle outstanding payable balance
supplemental schedule of noncash share-based compensation
changes in prepaid expenses associated with share-based compensation
warrant issued, related to loan payable
allowances related to
customer c
customer e
customer a
other allowances
payment of debt issuance cost
principal payments on loan payable
capital lease obligation incurred for purchases of equipment
see notes to condensed consolidated financial statements.
chromadex corporation and subsidiaries
condensed consolidated statements of cash flows
for the six month period ended july 2, 2016
adjustments to reconcile net income to net cash
used in operating activities:
natural product fine chemicals
inventory supplied free of charge to healthspan research, llc
gain on exchange of equipment
proceeds from sale of equipment
condensed consolidated balance sheet
january 3, 2015
assets
current assets
leasehold improvements and equipment
other noncurrent assets
total assets
liabilities and stockholders' equity
current liabilities
loan payable, less current maturities
capital lease obligations, less current maturities
deferred rent, less current
total liabilities
total stockholders' equity
total liabilities and stockholders' equity
retirement of fully depreciated equipment
gain on sale of equipment
condensed consolidated statements of operations
for the three month periods ended april 4, 2015 and march 29, 2014
sales
cost of sales
gross profit
operating expenses:
sales and marketing
general and administrative
operating expenses
operating income
nonoperating income
interest income
interest expense
nonoperating expenses
basic and diluted weighted-average common shares outstanding
proceeds from sale of assets
proceeds from exercise of warrants																										479,999	10,500
stock issued to settle outsanding payable balance
stock awards issued for services rendered in prior period
supplemental schedule of noncash activities related to
sale of bluscience consumer product line
assets transferred
liabilities transferred
carrying value of long-term investment in affiliate, net of 1,000,000 cash proceeds
purchase of intangible assets																											0	0	-30,000
supplemental schedule of noncash activities related to sale of bluscience consumer product line
carrying value of long-term investment in affiliate, net of 750,000 cash proceeds and 250,000 receivable
net (decrese) increase in cash
changes in stock awards issued for future services
carrying value of long-term investment in affiliate, net of 500,000 cash proceeds and 500,000 receivable
stock awards issued for services prior to the period
changes in stock and warrant awards issued for future services
gain on sale of assets
interest added to note receivable
consideration received, net of 750,000 cash proceeds
dietary supplements – raw materials
dietary supplements – work in process
dietary supplements – finished goods
consideration received, net of 500,000 cash proceeds
adjustments to reconcile net income to net cash (used in) operating activities:
depreciation																										81,962	80,866	77,287	74,633	66,208	68,331	67,926
net cash (used in) operating activities																											-343,933			-72,118	-206,364	-251,311
net cash (used in) investing activities																										-58,693	-45,311	-23,171	-86,277	-11,585	-9,263	-11,061
(used in) operating activities:
proceeds from issuance of common stock, net of offering costs
due to officers																											0
note 2: earnings per share
basic average common shares outstanding																										62,944,298	16,494,780			0	0	28,838,216
warrants and options in the money																										17,216,311	-254,160
weighted-average common shares outstanding assuming dilution																										87,118,959	16,240,620			0	0	28,838,216
provided by operating activities:
cash:
beginning																										2,226,459	0	0	471,378	0	0	1,125,504
ending																										2,895,777	-396,112	2,843,069	538,675	-105,150	-236,413	842,988
warrants and options not in the money																										6,958,350
proceeds from return of purchased equipment																														0
net cash (used in) financing activities																													-10,483
laboratory equipment																													2,330,933
leasehold improvements																													337,684
computer equipment																													209,916
furniture and fixtures																													15,308
office equipment																													3,445
construction in progress																													133,794
less accumulated depreciation																													1,581,047
stock issued for services provided
stock-based compensation expense																																46,962
interest added to notes payable
accounts receivable																														-81,068	35,711	-105,318
prepaid expenses and other																														-36,700	34,229	18,878
supplemental schedules of noncash financing activities
note payable incurred for repurchase of common stock
warrants and options in the money
adjustments to reconcile net loss to net cash used by operating activities:
common stock issued for debt
changes in operating assets and liabilities increase in accounts payable
net cash used by operating activities
common stock issued for cash
cash at beginning of period
cash at end of period
supplimental disclosures of cash flow information
cash paid for:
interest
income taxes
earnings
shares
per share amount
plan category
equity compensation plans approved by security holders
equity compensation plans not approved by security holders
total
adjustments to reconcile net income to net cash from operating activities
interest added to note payable
increase in
prepaid and other incomes
deposits
customer deposits and other liabilities
purchases of property and equipment
purchase of patents
principal payments on long-term debt
supplemental schedules of noncash investing and financing activities
dilutive potential shares

ChromaDex Corporation(NASDAQ:CDXC)

ChromaDex Corporation
(NASDAQ:CDXC)